Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study

Theo Pirich, Elisabeth Zwickl-Traxler, Martin Pecherstorfer, Josef Singer

Research output: Journal article (peer-reviewed) › Journal article

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science